-The Times of India NEW DELHI: The government has capped trade margins of 42 cancer drugs at 30% expanding the span of price control to curtail undue profiteering by chemists and drug stockists on various medicines which were so far outside price regulation. The move is expected to bring major relief to around 1.5 million cancer patients in India reeling under exponentially high treatment cost leading to heavy out-of-pocket expenditure. In a detailed...

-The Hindu Business Line MUMBAI: The government on Monday constituted a standing committee headed by Niti Aayog to oversee the drug pricing regime, a move which could clip the powers of drug pricing regulator, National Pharmaceutical Pricing Authority (NPPA). The Standing Committee on Affordable Medicines and Health Products will be headed by NITI Aayog member (health), and includes chief economic adviser, besides secretary department of health research, director general of health...

-The Indian Express The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings. New Delhi: After the National Pharmaceutical Pricing Authority (NPPA) imposed price caps on coronary stents in February last year, the Prime Minister’s Office (PMO) is documented as having “indicated” to representatives of foreign medical device companies in a meeting that the Indian government has no plans to...

-The Times of India NEW DELHI: In an attempt to revamp drug price regulation in the country, while strengthening implementation and market monitoring, the government is set to restructure the regulator, National Pharmaceutical Pricing Authority (NPPA). The authority, which is expected to be re-christened soon, will be replaced by a board or a council with four full-time members, including the chairman. The other three members — an economist, a costing specialist and...

-The Times of India NEW DELHI: The Delhi government is likely to come out with a policy to cap profit margins for hospitals this week. A first for any state, the policy will cover sale of medicines, consumables and devices to patients. The state government had appointed a nine-member committee in December last year to suggest the scope and process of capping prices. The move followed public outrage on the death of...